EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 178 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $234,000 | +4.9% | 6,910 | -9.9% | 0.01% | 0.0% |
Q1 2017 | $223,000 | -22.3% | 7,670 | -12.1% | 0.01% | -25.0% |
Q4 2016 | $287,000 | -43.2% | 8,730 | -45.5% | 0.01% | -46.7% |
Q3 2016 | $505,000 | +12.5% | 16,010 | +0.2% | 0.02% | +7.1% |
Q2 2016 | $449,000 | -8.9% | 15,980 | +17.8% | 0.01% | 0.0% |
Q1 2016 | $493,000 | -9.9% | 13,560 | -0.7% | 0.01% | -12.5% |
Q4 2015 | $547,000 | +98.2% | 13,660 | +40.8% | 0.02% | +77.8% |
Q3 2015 | $276,000 | -5.2% | 9,700 | +9.9% | 0.01% | +12.5% |
Q2 2015 | $291,000 | -25.4% | 8,830 | -34.9% | 0.01% | -27.3% |
Q1 2015 | $390,000 | +15.7% | 13,560 | +9.6% | 0.01% | +10.0% |
Q4 2014 | $337,000 | +13.5% | 12,370 | -11.4% | 0.01% | 0.0% |
Q3 2014 | $297,000 | -5.4% | 13,960 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $314,000 | +7.2% | 13,960 | +20.3% | 0.01% | +11.1% |
Q1 2014 | $293,000 | +7.3% | 11,604 | -2.1% | 0.01% | +12.5% |
Q4 2013 | $273,000 | +19.7% | 11,854 | -1.0% | 0.01% | +33.3% |
Q3 2013 | $228,000 | +36.5% | 11,974 | +3.5% | 0.01% | +50.0% |
Q2 2013 | $167,000 | – | 11,574 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |
Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |